To analyze the performance of iXip in the prediction of prostate cancer (PCa) and high-grade prostate cancer.
A consecutive series of men undergoing MRI/FUSION prostate biopsies were enrolled in one center.
To analyze the performance of iXip in the prediction of prostate cancer (PCa) and high-grade prostate cancer.
A consecutive series of men undergoing MRI/FUSION prostate biopsies were enrolled in one center.